Jefferies maintains Roivant Sciences at Buy; PT raised to $52
Jefferies maintains a Buy rating on Roivant Sciences and raises its price target to $52.00 per share from $42.00, per Benzinga/TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.